Senior Director, Market Access, Early Diagnosis and Screening

Summary

Join us in helping to revolutionize precision heartcare as a Sr. Director of Market Access, Early Diagnosis and Screening at HeartFlow, Inc., where you'll create and manage strategic elements for reimbursement process, secure coding and coverage, and drive adoption of new technologies.

Requirements

• Outstanding communication skills with demonstrated success in leading a cross-functional team in the development and execution of strategies for acquiring coding, coverage, and payment for new healthcare technologies
• Excellent knowledge of reimbursement mechanisms across markets specific to at-risk asymptomatic populations
• Excellent management and organization skills to build a high-functioning team of both internal employees and consultants
• Strong leadership skills for cross functional project groups
• Ability to lead development and presentation of models that demonstrate the clinical and economic impact of adopting and/or reimbursing new medical technologies in at-risk asymptomatic populations
• Greater than 8 years of demonstrated success in the area of health economics and reimbursement for medical devices, diagnostics, or pharmaceuticals, with strong connections to decision-making individuals and stakeholders in U.S. private and government payer organizations
• Minimum 4 years experience building, managing, and leading teams in Market Access, Payer Relations, and Health Economics required
• Bachelor’s degree required. Master’s preferred

Responsibilities

• Design and execute strategies with professional organizations to secure coding for HeartFlow's products in at-risk asymptomatic populations
• Work with senior leadership and other appropriate individuals from private and government payers and providers, in the US, to secure coverage and contracts in at-risk asymptomatic populations
• Develop relationships with payers post coverage to educate provider networks, design alternative payment models, and drive adoption of new technologies in at-risk asymptomatic populations
• Design and deliver communication vehicles for the clinical and economic value proposition for HeartFlow's products
• Create health economic analyses that can be translated into useful tools to be used by the clinical and commercial organizations
• Educate cross-functional teams on market access and reimbursement related items that pertain specifically to HeartFlow objectives in at-risk asymptomatic populations